Main Article Content
Abstract
Non-steroidal Anti-inflammatory drugs are the corner stone in the treatment acute and chronic pain in due to infection in musculoskeletal condition commonly in elderly patients. Piroxicam is used as an effective analgesic and anti-inflammatory agent in rheumatoid arthritis, osteoarthritis and acute pain in musculoskeletal disorders and acute gout.
Objective
Where as in controlled drug delivery systems designed for long term administered the drug level in the blood stream remains consort between the desired maximum and minimum for an extended period of time.
Methods
In the present study has been aimed at developing a enteric coated tablet of MT2 with a view of minimizing the drug release in physiological environment of stomach and small intestine and to ensure maximum drug relapse in the physiological environment (or) colon with least side effects.
Results
Piroxicam is anaxicam derivative medication belonging to non-steroidal anti-inflammatory drugs group, used to treat moderate to severe inflammatory diseases, such as arthritis and it reduces pain, joint swelling, and morning stiffness and improves the functionality of the joints during chronic polyarthritis.
Conclusion
The studies have a significant part for all characterization such as organoleptic properties, calibration curve, partition co-efficient etc: that are mated with standard values.